Molecular Surveillance In Early Breast Cancer Using The Tumor-Informed ctDNA Assay Myriad Genetics Precise MRD Test; A Prospective Observational Multicenter Study (The MRD Molecular Surveillance Study)
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
St. Jude Children's Research Hospital
Eastern Cooperative Oncology Group
National Institutes of Health Clinical Center (CC)
Assistance Publique - Hôpitaux de Paris
Methodist Health System
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Cofactor Genomics, Inc.
Duke University
Centre Hospitalier Universitaire, Amiens
NHS Lothian
University of Edinburgh
SciClone Pharmaceuticals
M.D. Anderson Cancer Center
Connecticut Children's Medical Center
Istituto Auxologico Italiano
Thomas Jefferson University
Metabiomics Corp
Institut Bergonié
AbbVie
University of Florida
Institut Bergonié
Institut Bergonié
M.D. Anderson Cancer Center
Institut Bergonié
DiaCarta, Inc.
Peking University
University of Colorado, Denver
Changchun GeneScience Pharmaceutical Co., Ltd.
Wake Forest University Health Sciences
Lanxi Hospital of Traditional Chinese Medicine
Takeda
City of Hope Medical Center
Medical College of Wisconsin
AIDS Malignancy Consortium
ProgenaBiome
ProgenaBiome
ProgenaBiome
ProgenaBiome
Mayo Clinic
Beth Israel Deaconess Medical Center
City of Hope Medical Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
EBG MedAustron GmbH
Thomas Jefferson University
Centre Hospitalier Universitaire de Nice
Shanghai Pulmonary Hospital, Shanghai, China